Individualized Drug Treatment for Treating Patients With Pancreatic Cancer
Status:
Terminated
Trial end date:
2010-04-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Treating tumor tissue in the laboratory with different drugs may help doctors find
the best drug for treating individual patients with pancreatic cancer.
PURPOSE: This phase II trial is studying an individualized drug treatment selection process,
based on laboratory results, for treating patients with pancreatic cancer that can be removed
by surgery.
Phase:
Phase 2
Details
Lead Sponsor:
Sidney Kimmel Comprehensive Cancer Center Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins